Micro and Nano Drug Delivery Systems for the Treatment of Oral Mucositis: A Review
Pharmaceutics · 07.08.2025 · 17 (8) · 1025
DOI: 10.3390/pharmaceutics17081025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.08.2025. Verfasst von Luciana Ângela Soares Maia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Synthesis and Drug Delivery, Paraiba State University, Rua Horácio Trajano de Oliveira, s/n, Cristo Redentor, João Pessoa 58075-540, PB…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Estadual da Paraíba, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, CAPES.
Abstract (Originalsprache)
Oral mucositis (OM) is a severe inflammatory condition of the oral mucosa that is commonly associated with cancer therapies. Traditional treatments typically have limited efficacy and significant side effects, necessitating alternative approaches. Nanobased drug delivery systems (DDSs) present promising solutions, enhancing therapeutic outcomes while minimizing side effects. This review aims to evaluate the use of nanobased DDSs to treat OM. To reach these aims, an extensive literature review was conducted using the following databases: BVS, PubMed, Scopus, and Web of Science. The search strategy included the keywords “microparticles,” “nanoparticles,” “drug delivery system,” “oral mucositis,” “therapy,” and “treatment,” combined with the Boolean operators “AND” and “OR.” After applying filters for language, relevance, full-text availability, exclusion of review articles, and removal of duplicates, a total of 32 articles were selected for analysis. Of the 32 studies included in this review, 25 employed polymeric micro- or nanosystems for the treatment of OM. Regarding the stage of investigation, 10 studies were conducted in vitro, 16 were conducted in vivo, and 6 corresponded to clinical trials. Compared with conventional drug delivery approaches, most of these studies reported improved therapeutic outcomes. These findings highlight the potential of nanosystems as innovative strategies for enhancing OM treatment. Nonetheless, challenges in large-scale manufacturing, including reproducibility and safety, and the limited number of clinical trials warrant careful consideration. Future research with larger clinical trials is essential to validate these findings and effectively guide clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Synthesis and Drug Delivery, Paraiba State University, Rua Horácio Trajano de Oliveira, s/n, Cristo Redentor, João Pessoa 58075-540, PB, Brazil.
ORCID-Profile: Carlos Alberto Arcelly Santos Bezerra, Elquio Eleamen Oliveira
Förderung
- Universidade Estadual da Paraíba
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- CAPES
- Paraiba State University
Zitieren
APA
Maia, L. Â. S., Siqueira, T. T. A., Bezerra, C. A. A. S., Farias, J. H. P., & Oliveira, E. E. (2025). Micro and Nano Drug Delivery Systems for the Treatment of Oral Mucositis: A Review. Pharmaceutics, 17(8), 1025. https://doi.org/10.3390/pharmaceutics17081025
Vancouver
Maia LÂS, Siqueira TTA, Bezerra CAAS, Farias JHP, Oliveira EE. Micro and Nano Drug Delivery Systems for the Treatment of Oral Mucositis: A Review. Pharmaceutics. 2025;17(8):1025. doi:10.3390/pharmaceutics17081025
BibTeX
@article{Maia2025,
author = {Maia, Luciana Ângela Soares and Siqueira, Tâmara Thaiane Almeida and Bezerra, Carlos Alberto Arcelly Santos and Farias, Jéssica Horana Pereira de and Oliveira, Elquio Eleamen},
title = {Micro and Nano Drug Delivery Systems for the Treatment of Oral Mucositis: A Review},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {8},
pages = {1025},
doi = {10.3390/pharmaceutics17081025}
}
EUVIMED